Cargando…

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches

Cognitive impairment in patients with Parkinson’s disease (PD) is one of the commonest and most disabling non-motor manifestations during the course of the disease. The clinical spectrum of PD-related cognitive impairment includes subjective cognitive decline (SCD), mild cognitive impairment (MCI) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Degirmenci, Yildiz, Angelopoulou, Efthalia, Georgakopoulou, Vasiliki Epameinondas, Bougea, Anastasia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608778/ https://www.ncbi.nlm.nih.gov/pubmed/37893474 http://dx.doi.org/10.3390/medicina59101756

Ejemplares similares

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study
por: Bougea, Anastasia, et al.
Publicado: (2023)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Psychosis in Parkinson’s Disease: A Lesson from Genetics
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Migraine, Tension-Type Headache and Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Ambiental Factors in Parkinson’s Disease Progression: A Systematic Review
por: Bougea, Anastasia, et al.
Publicado: (2023)

Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Outcomes in meningitis‑ventriculitis treated with intravenous or intrathecal plus intravenous colistin: A meta‑analysis
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

The Landscape of Monogenic Parkinson’s Disease in Populations of Non-European Ancestry: A Narrative Review
por: Koros, Christos, et al.
Publicado: (2023)

Role of miR‑200 family in brain metastases: A systematic review
por: Fotakopoulos, George, et al.
Publicado: (2023)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Prosopagnosia, Other Specific Cognitive Deficits, and Behavioral Symptoms: Comparison between Right Temporal and Behavioral Variant of Frontotemporal Dementia
por: Koros, Christos, et al.
Publicado: (2022)

How Telemedicine Can Improve the Quality of Care for Patients with Alzheimer’s Disease and Related Dementias? A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Implications of obesity and adiposopathy on respiratory infections; focus on emerging challenges
por: Lempesis, Ioannis G, et al.
Publicado: (2023)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Pulmonary function testing in patients with liver cirrhosis (Review)
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
por: Angelopoulou, Efthalia, et al.
Publicado: (2019)

Validation of NoSAS score for the screening of obstructive sleep apnea
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study
por: Koros, Christos, et al.
Publicado: (2023)

An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics
por: Durazzo, Alessandra, et al.
Publicado: (2020)

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson’s Disease and Asymptomatic Carriers of Related Genes: A Brief Report
por: Koros, Christos, et al.
Publicado: (2023)

COVID‑19 vaccination in liver transplant recipients (Review)
por: Gkoufa, Aikaterini, et al.
Publicado: (2023)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

Mild cognitive impairment in patients with Parkinson’s disease: An updated mini-review and future outlook
por: Yu, Rwei-Ling, et al.
Publicado: (2022)

Axillary Microbiota Is Associated with Cognitive Impairment in Parkinson’s Disease Patients
por: Arikan, Muzaffer, et al.
Publicado: (2022)

An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review
por: Bougea, Anastasia, et al.
Publicado: (2015)

Clock-Drawing Tasks as Predictive Measurements for Disease Classification Among Patients With Parkinson’s Disease and Essential Tremor
por: Bougea, Anastasia M, et al.
Publicado: (2021)

Parkinson's Disease and Cognitive Impairment
por: Yang, Yang, et al.
Publicado: (2016)

Cognitive impairment and dementia—an update
por: Massano, João
Publicado: (2012)

Recurrent Falls in People with Parkinson's Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors
por: Almeida, Lorena R. S., et al.
Publicado: (2014)

Pneumocystis jirovecii pneumonia in a X-linked chronic granulomatous disease female carrier
por: Kalotychou, Vasiliki, et al.
Publicado: (2021)

Role of stress in the pathogenesis of cancer (Review)
por: Lempesis, Ioannis G., et al.
Publicado: (2023)

Parkinson’s Disease–Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge
por: Cammisuli, Davide Maria, et al.
Publicado: (2019)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i473eoei6rpcmfopvd23n3521h